Epix Reports Positive Obesity Drug Data

CNBC.com: "LEXINGTON, Mass. - Epix Pharmaceuticals Inc. Monday reported positive data from an early-stage clinical trial for its drug candidate to treat obesity. Findings from the trial of 21 obese, but otherwise healthy adults, showed those taking the developmental drug PRX-07034 for 28 days lost weight while adults on placebo gained weight. Patients taking 600 milligrams of PRX-07034 twice daily lost an average of 1 pound, while adults on placebo gained 3 pounds. The biopharmaceutical company said the results were statistically significant."